This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,343.40 firm fixed-price delivery order is for the supply of Micardis HCT 40-12.5 mg tablets, with a period of performance through November 29, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. This award demonstrates AmerisourceBergen's extensive capability to supply a diverse portfolio of critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, and medical devices, to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Generated 2/26/25, 10:03 AM